ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Histogenics Corporation

Histogenics Corporation (HSGX)

0.162
0.00
(0.00%)
Closed September 18 4:00PM
0.162
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.162
Bid
0.164
Ask
0.166
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.162
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
256,502,000
Dividend Yield
-
PE Ratio
-4.55
Earnings Per Share (EPS)
-0.25
Revenue
6.04M
Net Profit
-63.08M

About Histogenics Corporation

Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to tre... Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. Histogenics operates in two geographic regions: The United States (Massachusetts) and Israel (Tel Aviv). Regenerative medicine technologies encompass a variety of therapeutic approaches, including tissue engineering, cell-based therapies, gene therapy, small molecules and biologics, stem cells and biobanking. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Ortho,prosth,surg Appl,suply
Website
Headquarters
Wilmington, Delaware, USA
Founded
2020

HSGX Latest News

Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

BOSTON and JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan...

Histogenics Corporation Announces Approval of Merger by Stockholders at Special Meeting

BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that all proposals related to its proposed merger with Ocugen...

Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019

BOSTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it convened and then adjourned, without conducting any...

Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting

BOSTON, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it intends to convene and then adjourn, without conducting...

Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel...

BOSTON, Mass. and MALVERN, Penn., April 08, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a privately held clinical-stage biopharmaceutical company focused...

Jonathan Lieber Joins Danforth Advisors as Managing Director

SOMERVILLE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Danforth Advisors, LLC, a consulting firm providing operational accounting and finance support, together with CFO services, for private and...

Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway

WALTHAM, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), today provided an update on the NeoCart regulatory pathway based on discussions with the...

Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway

WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...

Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results

WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ‒ Histogenics and FDA Continue Discussions on NeoCart® Phase 3 Data and Potential BLA Submission ‒‒ October 2018 Financing Expected to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZEOZeo Energy Corporation
$ 4.76
(317.54%)
631.91k
XCURExicure Inc
$ 7.03
(206.99%)
1.43M
VEROVenus Concept Inc
$ 0.9219
(83.46%)
1.64M
TBIOTelesis Bio Inc
$ 1.74
(27.94%)
29.79k
SPISPI Energy Company Ltd
$ 0.4979
(27.57%)
3.8k
PGNYProgyny Inc
$ 18.75
(-23.28%)
14.1k
VEEAVeea Inc
$ 10.30
(-15.92%)
9.19k
WBUYWeBuy Global Ltd
$ 0.1552
(-15.79%)
194.58k
RNAZTransCode Therapeutics Inc
$ 0.3064
(-12.46%)
6.32k
ALLRAllarity Therapeutics Inc
$ 2.08
(-9.57%)
4.3k
FRGTFreight Technologies Inc
$ 0.155
(25.10%)
6.81M
VEROVenus Concept Inc
$ 0.9219
(83.46%)
1.64M
XCURExicure Inc
$ 7.03
(206.99%)
1.43M
SQQQProShares UltraPro Short QQQ
$ 7.96
(-5.24%)
1.06M
EJHE Home Household Service Holdings Ltd
$ 0.112
(5.66%)
900.07k

Discussion

View Full Feed
falkus951 falkus951 4 minutes ago
$LUXH 1:00 AM PST VOLUME TRADING UP% pre market

CEO with STRONG hotel management exp bought shares of stock last month. + NO R/S. He knows something
1. Insider Purchase http://openinsider.com/search?q=luxh
2. https://stockcharts.com/sc3/ui/?s=LUXH&id=p07205851717
LUXH
RickNagra RickNagra 5 minutes ago
Oh wow. I sm exactly expecting a massive super duper big win from the team and the players. No doubt Ron is a real person or even a politician or a genius. He knows everything. A literal legend and a great leader. Everyone should raise their glass to the world Ron. Please allow me to share my
GNCP
Ms Labonte Ms Labonte 5 minutes ago
Going to the next level penny flipper$$$ .50 coming today… buy you all out ….
RNAZ
falkus951 falkus951 5 minutes ago
$LUXH 1:00 AM PST VOLUME TRADING UP% pre market

CEO with STRONG hotel management exp bought shares of stock last month. + NO R/S. He knows something
1. Insider Purchase http://openinsider.com/search?q=luxh
2. https://stockcharts.com/sc3/ui/?s=LUXH&id=p07205851717
LUXH
Ms Labonte Ms Labonte 6 minutes ago
My pimp$ got their eye$ on you flipper$$$$
RNAZ
tw0122 tw0122 8 minutes ago
$28 keep on pumping PPT $30 closer
SVIX
tw0122 tw0122 9 minutes ago
Told you $70 coming PPT team pumping markets hard early on
TQQQ
tw0122 tw0122 12 minutes ago
TBIO 3.80 + 180% push it more honest hedge funds we luv it
TBIO
tw0122 tw0122 13 minutes ago
Missing out on ZEO TBIO and FRGT wake up lol
FRGT TBIO ZEO
tw0122 tw0122 14 minutes ago
Pump it more $3.20 + 120% now. I luv Gary Gensler
TBIO
jrsh jrsh 15 minutes ago
Yep, unbelievable, they just don't get it that announcements without following through are undermining trust and confidence big time and it would be much better to hold back until being sure!!!

They still owe us several game changers, great news ahead and other information!!!
NSAV
Ms Labonte Ms Labonte 15 minutes ago
.50 on radar $creen today… lookout for leg$$ $trait up$$$$
CREEN TRAIT
dennisdave dennisdave 17 minutes ago
Yes
And at ASM they said they haven’t even started the process of writing the pricing model to submit for appraisal as far as I remember and no timeline was given ( unless you consider several months as a timeline )

I know that is one reason we have tanked 32% since then. But t
ASM NWBO
snow snow 20 minutes ago
I listened to part of the interview. I was not impressed by the performance of management. What is positive is that the company will try to expand the sms business that has better profit margins than the voice business. If I did not misunderstand the hope is to improve the bottom line by two million
IQST
toohot toohot 20 minutes ago
Everything at BIEL is progressing. Don’t let the egg sucking dogs detour your beliefs!





BUY $BIEL$
BIEL
tw0122 tw0122 21 minutes ago
Zeo $6 + 400% let’s go
ZEO
tw0122 tw0122 21 minutes ago
zeo to the moon $5 + 300% pump it baby
ZEO
Money hunt Money hunt 22 minutes ago
No reverse news coming !! partnership agreement with IBM in the works!!!
FOXO
tw0122 tw0122 23 minutes ago
.19 +’53% we love Bayer
FRGT
tw0122 tw0122 24 minutes ago
Pump it .18s for a 40% gain
FRGT
tw0122 tw0122 26 minutes ago
NVDL $54 those $51s and $52s nice 6% flip at premarket open Yellen and Powell
Pump the markets at play enjoy
NVDA

Your Recent History

Delayed Upgrade Clock